Viridian Therapeutics Inc. (VRDN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Viridian Therapeutics Inc...

    NASDAQ: VRDN · Real-Time Price · USD
    19.98
    0.90 (4.72%)
    At close: Sep 26, 2025, 1:36 PM

    Viridian Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 302K 314K 1.77M 2.96M
    Cost of Revenue
    		 n/a 1.32M 755K 620K
    Gross Profit
    		 302K -1.01M 1.02M 2.34M
    Operating Income
    		 -299.04M -254.45M -134.3M -79.73M
    Interest Income
    		 32.13M 18.56M 4.92M 318K
    Pretax Income
    		 -269.95M -237.73M -129.87M -79.41M
    Net Income
    		 -269.95M -237.73M -125.44M -79.42M
    Selling & General & Admin
    		 61.08M 95M 35.18M 25.8M
    Research & Development
    		 238.25M 159.76M 100.89M 56.89M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 299.34M 254.76M 136.08M 82.69M
    Interest Expense
    		 3.05M 1.85M 486K 3K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 299.34M 254.76M 136.08M 82.69M
    Income Tax Expense
    		 n/a n/a -4.43M 3K
    Shares Outstanding (Basic)
    		 67.89M 44.76M 32.09M 11.92M
    Shares Outstanding (Diluted)
    		 67.89M 44.76M 32.09M 11.92M
    EPS (Basic)
    		 -3.98 -5.31 -3.91 -6.66
    EPS (Diluted)
    		 -3.98 -5.31 -3.91 -6.66
    EBITDA
    		 -265.66M -234.56M -128.63M -78.79M
    EBIT
    		 -266.9M -235.89M -129.39M -79.41M
    Depreciation & Amortization
    		 1.24M 522K 755K 620K

    Add to Watchlist